Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatitis B in 2014: HBV research moves forward--receptors and reactivation.

Literature DB >> 25511530

Hepatitis B in 2014: HBV research moves forward--receptors and reactivation.

Man-Fung Yuen¹, Ching-Lung Lai¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2014 PMID： 25511530 DOI： 10.1038/nrgastro.2014.226

Source DB: PubMed Journal: Nat Rev Gastroenterol Hepatol ISSN： 1759-5045 Impact factor: 46.802

× No keyword cloud information.

10 in total

1. Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab.

Authors: I Dervite; D Hober; P Morel
Journal: N Engl J Med Date: 2001-01-04 Impact factor: 91.245

Review 2. Strategies to inhibit entry of HBV and HDV into hepatocytes.

Authors: Stephan Urban; Ralf Bartenschlager; Ralf Kubitz; Fabien Zoulim
Journal: Gastroenterology Date: 2014-04-25 Impact factor: 22.682

3. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study.

Authors: Chiun Hsu; Hsiao-Hui Tsou; Shyh-Jer Lin; Ming-Chung Wang; Ming Yao; Wen-Li Hwang; Woei-Yau Kao; Chang-Fang Chiu; Sheng-Fung Lin; Johnson Lin; Cheng-Shyong Chang; Hwei-Fang Tien; Tsang-Wu Liu; Pei-Jer Chen; Ann-Lii Cheng
Journal: Hepatology Date: 2014-04-14 Impact factor: 17.425

4. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.

Authors: Huan Yan; Bo Peng; Yang Liu; Guangwei Xu; Wenhui He; Bijie Ren; Zhiyi Jing; Jianhua Sui; Wenhui Li
Journal: J Virol Date: 2014-01-03 Impact factor: 5.103

5. Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports.

Authors: A M Evens; B D Jovanovic; Y-C Su; D W Raisch; D Ganger; S M Belknap; M-S Dai; B-C C Chiu; B Fintel; Y Cheng; S-S Chuang; M-Y Lee; T-Y Chen; S-F Lin; C-Y Kuo
Journal: Ann Oncol Date: 2010-11-29 Impact factor: 32.976

6. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.

Authors: Yi Ni; Florian A Lempp; Stefan Mehrle; Shirin Nkongolo; Christina Kaufman; Maria Fälth; Jan Stindt; Christian Königer; Michael Nassal; Ralf Kubitz; Holger Sültmann; Stephan Urban
Journal: Gastroenterology Date: 2013-12-19 Impact factor: 22.682

7. Hepatitis B virus persistence after recovery from acute viral hepatitis.

Authors: T I Michalak; C Pasquinelli; S Guilhot; F V Chisari
Journal: J Clin Invest Date: 1994-01 Impact factor: 14.808

8. Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.

Authors: Wai-Kay Seto; Thomas S Y Chan; Yu-Yan Hwang; Danny Ka-Ho Wong; James Fung; Kevin Sze-Hang Liu; Harinder Gill; Yuk-Fai Lam; Albert K W Lie; Ching-Lung Lai; Yok-Lam Kwong; Man-Fung Yuen
Journal: J Clin Oncol Date: 2014-10-06 Impact factor: 44.544

9. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.

Authors: Huan Yan; Guocai Zhong; Guangwei Xu; Wenhui He; Zhiyi Jing; Zhenchao Gao; Yi Huang; Yonghe Qi; Bo Peng; Haimin Wang; Liran Fu; Mei Song; Pan Chen; Wenqing Gao; Bijie Ren; Yinyan Sun; Tao Cai; Xiaofeng Feng; Jianhua Sui; Wenhui Li
Journal: Elife Date: 2012-11-13 Impact factor: 8.140

10. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP).

Authors: Koichi Watashi; Ann Sluder; Takuji Daito; Satoko Matsunaga; Akihide Ryo; Shushi Nagamori; Masashi Iwamoto; Syo Nakajima; Senko Tsukuda; Katyna Borroto-Esoda; Masaya Sugiyama; Yasuhito Tanaka; Yoshikatsu Kanai; Hiroyuki Kusuhara; Masashi Mizokami; Takaji Wakita
Journal: Hepatology Date: 2014-04-01 Impact factor: 17.425

10 in total

6 in total

1. PRKAA/AMPK restricts HBV replication through promotion of autophagic degradation.

Authors: Na Xie; Kefei Yuan; Li Zhou; Kui Wang; Hai-Ning Chen; Yunlong Lei; Jiang Lan; Qinqin Pu; Wei Gao; Lu Zhang; Guobo Shen; Qifu Li; Hengyi Xiao; Hong Tang; Rong Xiang; Mingliang He; Pinghui Feng; Edouard C Nice; Yuquan Wei; Haiyuan Zhang; Jiayin Yang; Canhua Huang
Journal: Autophagy Date: 2016-06-15 Impact factor: 16.016

6. Diagnostic Estimation of Noninvasive Tests for Hepatic Fibrosis in Chronic Hepatitis B Patients Without a Gold Standard.

Authors: Yi Xiang Zheng; Shu Juan Ma; Meng Hou Lu
Journal: Hepat Mon Date: 2016-02-16 Impact factor: 0.660